BG34-200 Immunotherapy of Advanced Melanoma

SIMPLE SUMMARY: Immunotherapy using immune checkpoint inhibitors is now the first line standard of care for advanced melanoma but >50% of patients still do not benefit. Using a recently developed plant-derived glucan molecule called BG34-200, we found that targeting elements of the myeloid compon...

Descripción completa

Detalles Bibliográficos
Autores principales: Roche, Veronique, Sandoval, Victor, Senders, Zachary, Lyons, Joshua, Wolford, Claire, Zhang, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736444/
https://www.ncbi.nlm.nih.gov/pubmed/36497393
http://dx.doi.org/10.3390/cancers14235911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736444/
https://www.ncbi.nlm.nih.gov/pubmed/36497393
http://dx.doi.org/10.3390/cancers14235911

Ejemplares similares